Stopping advanced prostate cancer by disrupting its molecular “conversations”
Aim of the project
We aim to uncover how two key proteins—HOXB13 and AR—work together to drive aggressive prostate cancer. Blocking their interaction may lead to new treatments for patients with therapy-resistant tumors, offering better options when therapies are no longer effective.
We are leading Spanish society’s efforts to reduce the impact of cancer and improve people’s lives.
Headquarters:
C/ Teniente Coronel Noreña, 30, 28045 – Madrid
We are leading Spanish society’s efforts to reduce the impact of cancer and improve people’s lives.
Headquarters:
C/ Teniente Coronel Noreña, 30, 28045 – Madrid
2026 © Asociación Española Contra el Cáncer | Powered by Scienseed